SCHEMBL7967988

SCHEMBL7967988

COc1ccc(-c2ccc(C=CC(=O)O)cc2)cc1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.89
ATM Q13315 1/20 0.89
HDAC8 Q9BY41 3/20 0.71
HDAC6 Q9UBN7 3/20 0.71
HDAC3 O15379 2/20 0.71
HDAC1 Q13547 2/20 0.71
HDAC2 Q92769 2/20 0.71
HDAC4 P56524 1/20 0.71
HDAC7 Q8WUI4 1/20 0.71
HDAC10 Q969S8 1/20 0.71
HDAC11 Q96DB2 1/20 0.71
HDAC9 Q9UKV0 1/20 0.71
HDAC5 Q9UQL6 1/20 0.71
F3 P13726 2/20 0.68
GSK3B P49841 2/20 0.64
BACE1 P56817 1/20 0.63
BCHE P06276 1/20 0.61
CYP3A4 P08684 1/20 0.61
NFKB1 P19838 1/20 0.61
NFKB2 Q00653 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7967986 1.00 THRB (0.89) THRBATMHDAC8HDAC6HDAC3
SCHEMBL12473720 1.00 THRB (0.89) THRBATMHDAC8HDAC6HDAC3
4-Methoxycinnamic Acid SCHEMBL58700 0.94 THRB (1.00) THRBATMHDAC8HDAC6HDAC3
4-Methoxycinnamic Acid SCHEMBL12473722 0.94 THRB (1.00) THRBATMHDAC8HDAC6HDAC3
4-Methoxycinnamic Acid SCHEMBL58699 0.94 THRB (1.00) THRBATMHDAC8HDAC6HDAC3
4-Methoxycinnamic Acid SCHEMBL10935651 0.93 THRB (0.96) THRBATMHDAC8HDAC6HDAC3
4-Methoxycinnamic Acid SCHEMBL8500105 0.93 THRB (0.96) THRBATMHDAC8HDAC6HDAC3
4-Methoxycinnamic Acid SCHEMBL5330605 0.93 THRB (0.96) THRBATMHDAC8HDAC6HDAC3
4-Methoxycinnamic Acid SCHEMBL4654596 0.93 THRB (0.96) THRBATMHDAC8HDAC6HDAC3
4-Methoxycinnamic Acid SCHEMBL5330596 0.93 THRB (0.96) THRBATMHDAC8HDAC6HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2595952-B1 AGONISTS OF GPR40 CONNEXIOS LIFE SCIENCES PVT LTD (IN) 2020-11-18 EP disclosed
US-9278915-B2 Agonists of GPR40 CONNEXIOS LIFE SCIENCES PVT LTD (IN) 2016-03-08 US disclosed
US-20130237571-A1 AGONISTS OF GPR40 Conexios Life Sciences PVT. LTD. (IN) 2013-09-12 US disclosed
EP-2595952-A1 AGONISTS OF GPR40 Connexios Life Sciences Pvt. Ltd. (IN) 2013-05-29 EP disclosed
WO-2012011125-A1 AGONISTS OF GPR40 CONNEXIOS LIFE SCIENCES PVT. LTD. (IN) 2012-01-26 WO disclosed
US-6277502-B1 ORGANOSILICON POLYMERS; LIQUID CRYSALS ROLIC AG (CH) 2001-08-21 US disclosed
US-5139696-A Hydrogen-bonded liquid crystal complexes CORNELL RESEARCH FOUNDATION, INC. (US) 1992-08-18 US disclosed
US-5037574-A Hydrogen-bonded liquid crystal complexes CORNELL RESEARCH FOUNDATION, INC. (US) 1991-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130237571-A1 AGONISTS OF GPR40 GPR65, GPR55, GPR68 THRB 489/4885ATM 4366/4885HDAC8 1591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.